FibroBiologics, Inc.

FBLG

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001493152-26-008903
Filing date: Mar 4, 2026
Earliest execution date: Mar 2, 2026
Reporting Owners: O'HEERON PETE (CEO)

Summary

Type

Buy

Net shares

+51,500

% of shares

0.87%

Amount (USD)

$19,530

Insider confidence score

68.8 out of 100

Positive

  • Significant buy (≥0.5% of shares)

Negative

  • Small buy amount (<$50K)

Stock transactions

Transaction 1

Security

Common Stock

Action

Buy

Date

2026-03-02

Code

P

Net shares

+17,428.0

Price per Share

$0.35

Amount (USD)

$6,152.08

Acquired/Disposed

Acquired

Shares Owned Before

5,906,647.0

Shares Owned After

5,924,075.0

Transaction 2

Security

Common Stock

Action

Buy

Date

2026-03-03

Code

P

Net shares

+18,200.0

Price per Share

$0.41

Amount (USD)

$7,372.82

Acquired/Disposed

Acquired

Shares Owned Before

5,924,075.0

Shares Owned After

5,942,275.0

Transaction 3

Security

Common Stock

Action

Buy

Date

2026-03-04

Code

P

Net shares

+15,872.0

Price per Share

$0.38

Amount (USD)

$6,005.96

Acquired/Disposed

Acquired

Shares Owned Before

5,942,275.0

Shares Owned After

5,958,147.0

Filing's footnotes

1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.3210 to $0.4166 on March 2, 2026, $0.3885 to $0.4302 on March 3, 2026, and $0.3730 to $0.3820 on March 4, 2026. The reporting person will provide upon request to the SEC, the Issuer, or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.